BIRC5 and lung carcinoma: Preclinical research showed that YM155 can effectively decrease survivin expression levels in various cancer cell lines and inhibit tumor growth in xenografts mouse models, including prostate cancer, non-Hodgkin lymphoma, and lung cancer [127,128].